http://orcid.org/0000-0002-2398-487X
Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Basharat Ahmad Bhat, Ifra Saifi, Nizar A. Khamjan, Syed Suhail Hamdani, Abdullah Algaissi, Safeena Rashid, Mohammed M Alshehri, Showkat Ahmad Ganie, Mohtashim Lohani, Siddig Ibrahim Abdelwahab & Sajad Ahmad Dar. (2023) Exploring the tumor immune microenvironment in ovarian cancer: a way-out to the therapeutic roadmap. Expert Opinion on Therapeutic Targets 0:0.
Read now
Read now
Yan Lv, Xiao Ma, Yuxin Du & Jifeng Feng. (2021) Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets. OncoTargets and Therapy 14, pages 589-607.
Read now
Read now
Articles from other publishers (48)
A. H. Murtadha, N. A. Sharudin, I. I. M. Azahar, A. T. Che Has & N. F. Mokhtar. (2023) Upregulation of MHC I Antigen Processing Machinery Gene Expression in Breast Cancer Cells by Trichostatin A. Molecular Biology 57:6, pages 1212-1227.
Crossref
Crossref
Rachel SJ Wong, Rebecca JM Ong & Joline SJ Lim. (2023) Immune checkpoint inhibitors in breast cancer: development, mechanisms of resistance and potential management strategies. Cancer Drug Resistance 6:4, pages 768-87.
Crossref
Crossref
Nadeem S. Butt, Maher Kurdi, Motaz M. Fadul, Sahar Hakamy, Bassam M.J. Addas, Eyad Faizo, Shadi Alkhayyat, Ahmed K. Bamaga, Taghreed Alsinani, Yousef Katib, Fahad Okal, Yazid Maghrabi, Abdulrahman J. Sabbagh, Rana Moshref, Sultan Albalawi, Alaa Alkhotani, Fawaz Mohammed, Nasser Mulla & Saleh Baeesa. (2023) Major Histocompatibility Class-I (MHC-I) downregulation in glioblastoma is a poor prognostic factor but not a predictive indicator for treatment failure. Pathology - Research and Practice 250, pages 154816.
Crossref
Crossref
Svetlana V. Chulkova, Elena N. Sholokhova, Irina V. Poddubnaya, Ivan S. Stilidi, Dmitrii A. Burov & Nikolai N. Tupitsyn. (2023) Interrelation of HLA-I and class II major histocompatibility complex molecules with clinical and morphological signs of breast cancer: A retrospective cohort study. Journal of Modern Oncology 25:2, pages 208-213.
Crossref
Crossref
Katrin Raute, Juliane Strietz, Maria Alejandra Parigiani, Geoffroy Andrieux, Oliver S. Thomas, Klaus M. Kistner, Marina Zintchenko, Peter Aichele, Maike Hofmann, Houjiang Zhou, Wilfried Weber, Melanie Boerries, Mahima Swamy, Jochen Maurer & Susana Minguet. (2023)
Breast Cancer Stem Cell–Derived Tumors Escape from γδ T-cell Immunosurveillance
In Vivo
by Modulating γδ T-cell Ligands
. Cancer Immunology Research 11:6, pages 810-829.
Crossref
Crossref
Marta Wagner, Maciej Sobczyński, Monika Jasek, Konrad Pawełczyk, Irena Porębska, Piotr Kuśnierczyk & Andrzej Wiśniewski. (2023) Down-regulation of ERAP1 mRNA expression in non-small cell lung cancer. BMC Cancer 23:1.
Crossref
Crossref
Nhat-Chau TRUONG, Nhi-Thao HUYNH, Kmuong-Duy PHAM & Phuc-Van PHAM. (2023) Roles of cancer stem cells in cancer immune surveillance. Minerva Biotechnology and Biomolecular Research 35:1.
Crossref
Crossref
D. A. Ryabchikov, S. V. Chulkova, S. D. Zheltikov, A. A. Osipova & N. N. Tupitsyn. (2023) Immunological characteristics of primary tumor and bone marrow in patients with breast cancer. Medical alphabet:31, pages 23-27.
Crossref
Crossref
S. V. Chulkova, E. N. Sholokhova, I. V. Poddubnaya, I. S. Stylidi & N. N. Tupitsyn. (2022) Expression of monomorphic HLA-determinants, transferrin receptor 1 (TfR1) in molecular subtypes of breast cancer. Russian Journal of Biotherapy 21:4, pages 50-61.
Crossref
Crossref
Prabhavi Wijesiriwardhana, Anthony M. Musolf, Joan E. Bailey-Wilson, T. Kalum Wetthasinghe & Vajira H. W. Dissanayake. (2022) Genome-wide linkage search for cancer susceptibility loci in a cohort of non BRCA1/2 families in Sri Lanka. BMC Research Notes 15:1.
Crossref
Crossref
S. V. Chulkova, E. N. Sholokhova, I. V. Poddubnaya, E. V. Artamonova, A. V. Semyanikhina, I. S. Stylidi & N. N. Tupitsyn. (2022) Immunophenotypic features of molecular subtypes of breast cancer. Medical alphabet:26, pages 20-26.
Crossref
Crossref
Brendan T. McKeown, Nicholas J. Relja, Steven R. Hall, Simon Gebremeskel, Jeanna M. MacLeod, Chansey J. Veinotte, Leah G. Bennett, Leanne B. Ohlund, Lekha Sleno, David L. Jakeman, Jason N. Berman, Brent Johnston & Kerry B. Goralski. (2022) Pilot study of jadomycin B pharmacokinetics and anti-tumoral effects in zebrafish larvae and mouse breast cancer xenograft models. Canadian Journal of Physiology and Pharmacology 100:11, pages 1065-1076.
Crossref
Crossref
Casey Moore, Joonbeom Bae, Longchao Liu, Huiyu Li, Yang-Xin Fu & Jian Qiao. (2022) Exogenous signaling repairs defective T cell signaling inside the tumor microenvironment for better immunity. JCI Insight 7:17.
Crossref
Crossref
Rocío Villalobos-Manzo, Emmanuel Ríos-Castro, José Manuel Hernández-Hernández, Goldie Oza, Mauricio A. Medina & José Tapia-Ramírez. (2022) Identification of Transferrin Receptor 1 (TfR1) Overexpressed in Lung Cancer Cells, and Internalization of Magnetic Au-CoFe2O4 Core-Shell Nanoparticles Functionalized with Its Ligand in a Cellular Model of Small Cell Lung Cancer (SCLC). Pharmaceutics 14:8, pages 1715.
Crossref
Crossref
S. V. Chulkova, E. N. Sholokhova, I. V. Poddubnaya, I. S. Stylidi & N. N. Tupitsyn. (2022) HLA-monomorphic determinants of the primary tumor in breast cancer patients. Russian Journal of Biotherapy 21:2, pages 56-66.
Crossref
Crossref
Alexander Ring, Maria Spataro, Andreas Wicki & Nicola Aceto. (2022) Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Erin N. Hunt, Jonathan P. Kopacz & Deborah J. Vestal. (2022) Unraveling the Role of Guanylate-Binding Proteins (GBPs) in Breast Cancer: A Comprehensive Literature Review and New Data on Prognosis in Breast Cancer Subtypes. Cancers 14:11, pages 2794.
Crossref
Crossref
Nicola Hoppmann, Nora Heinig, Ute Distler, Ella Kim, Volker Lennerz, Yvonne Krauß, Ulrike Schumann, Alf Giese, Stefan Tenzer, Lynn Bitar & Mirko H. H. Schmidt. (2022) Gamma Irradiation Triggers Immune Escape in Glioma-Propagating Cells. Cancers 14:11, pages 2728.
Crossref
Crossref
Karama Asleh, Gian Luca Negri, Sandra E. Spencer Miko, Shane Colborne, Christopher S. Hughes, Xiu Q. Wang, Dongxia Gao, C. Blake Gilks, Stephen K. L. Chia, Torsten O. Nielsen & Gregg B. Morin. (2022) Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes. Nature Communications 13:1.
Crossref
Crossref
Harishini Rajaratinam, Noor Fatmawati Mokhtar, Nurul Asma-Abdullah & Wan Ezumi Mohd Fuad. (2022) Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives. Biomolecules 12:2, pages 310.
Crossref
Crossref
Jessica J. Roetman, Minna K. I. Apostolova & Mary Philip. (2022) Viral and cellular oncogenes promote immune evasion. Oncogene 41:7, pages 921-929.
Crossref
Crossref
Yijun Li, Xiaoxu Liu, Heyan Chen, Peiling Xie, Rulan Ma, Jianjun He & Huimin Zhang. (2021) Bioinformatics analysis for the role of CALR in human cancers. PLOS ONE 16:12, pages e0261254.
Crossref
Crossref
Minhong Shen, Heath A. Smith, Yong Wei, Yi-Zhou Jiang, Sheng Zhao, Nicole Wang, Michelle Rowicki, Yong Tang, Xiang Hang, Songyang Wu, Liling Wan, Zhi-Ming Shao & Yibin Kang. (2021) Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer. Nature Cancer 3:1, pages 60-74.
Crossref
Crossref
Ann Hanna & Justin M. Balko. (2021) Breast cancer resistance mechanisms: challenges to immunotherapy. Breast Cancer Research and Treatment 190:1, pages 5-17.
Crossref
Crossref
Adam Nelson, Jordan D. Lukacs & Brent Johnston. (2021) The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead. Cancers 13:20, pages 5174.
Crossref
Crossref
Sen Yang, Dongfang Tang, Yu Chen Zhao, Hongliang Liu, Sheng Luo, Thomas E. Stinchcombe, Carolyn Glass, Li Su, Sipeng Shen, David C. Christiani, Qiming Wang & Qingyi Wei. (2021) Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival. Cancer Immunology, Immunotherapy 70:10, pages 2819-2833.
Crossref
Crossref
Nina Radosevic-Robin, Pier Selenica, Yingjie Zhu, Helen H. Won, Michael F. Berger, Lorenzo Ferrando, Emiliano Cocco, Maud Privat, Flora Ponelle-Chachuat, Catherine Abrial, Jean-Marc Nabholtz, Frederique Penault-Llorca, Jorge S. Reis-Filho & Maurizio Scaltriti. (2021) Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies. npj Breast Cancer 7:1.
Crossref
Crossref
Xupeng Bai, Jie Ni, Julia Beretov, Peter Graham & Yong Li. (2021) Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance. Journal of the National Cancer Center 1:3, pages 75-87.
Crossref
Crossref
Jun Li, Lusong Tian, Zongpan Jing, Zhengguang Guo, Peng Nan, Fang Liu, Shuangmei Zou, Lijun Yang, Xiufeng Xie, Ying Zhu, Yue Zhao, Wei Sun, Yulin Sun & Xiaohang Zhao. (2021) Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis. Cancer Letters 516, pages 13-27.
Crossref
Crossref
Pere Llinàs-Arias, Sandra Íñiguez-Muñoz, Kelly McCann, Leonie Voorwerk, Javier I. J. Orozco, Miquel Ensenyat-Mendez, Borja Sesé, Maggie L. DiNome & Diego M. Marzese. (2021) Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer. Cancers 13:16, pages 4139.
Crossref
Crossref
Denis A. Ryabchikov, Svetlana V. Chulkova, Farhad A. Shamilov, Nail V. Chanturia, Sergey D. Zheltikov & Nikolai N. Tupitsyn. (2021) Breast cancer immunophenotype and its relationship with haematopoiesis. Journal of Modern Oncology 23:2, pages 275-279.
Crossref
Crossref
Jiacheng Shen, Tingwei Liu, Qiaoli Bei & Shaohua Xu. (2021) Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis. Frontiers in Oncology 11.
Crossref
Crossref
Changjing Cai, Jie Long, Qiaoqiao Huang, Ying Han, Yinghui Peng, Cao Guo, Shanshan Liu, Yihong Chen, Edward Shen, Kexin Long, Xinwen Wang, Jian Yu, Hong Shen & Shan Zeng. (2021) M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Karthik Dhatchinamoorthy, Jeff D. Colbert & Kenneth L. Rock. (2021) Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Frontiers in Immunology 12.
Crossref
Crossref
Simon Gebremeskel, Adam Nelson, Brynn Walker, Tora Oliphant, Lynnea Lobert, Douglas Mahoney & Brent Johnston. (2021) Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis. Journal for ImmunoTherapy of Cancer 9:3, pages e002096.
Crossref
Crossref
Yuanzhang Fang, Lifei Wang, Changlin Wan, Yifan Sun, Kevin Van der Jeught, Zhuolong Zhou, Tianhan Dong, Ka Man So, Tao Yu, Yujing Li, Haniyeh Eyvani, Austyn B. Colter, Edward Dong, Sha Cao, Jin Wang, Bryan P. Schneider, George E. Sandusky, Yunlong Liu, Chi Zhang, Xiongbin Lu & Xinna Zhang. (2021) MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation. Journal of Clinical Investigation 131:1.
Crossref
Crossref
Ioana-Ecaterina Pralea, Radu-Cristian Moldovan, Adrian-Bogdan Țigu, Corina Ionescu & Cristina-Adela Iuga. (2020) Mass Spectrometry-Based Omics for the Characterization of Triple-Negative Breast Cancer Bio-Signature. Journal of Personalized Medicine 10:4, pages 277.
Crossref
Crossref
Ningfei Guo, Yue Wen, Can Wang, Lifei Kang, Xiuqing Wang, Xiaoyi Liu, Athena M. Soulika, Bowei Liu, Mei Zhao, Xiaojing Han, Ping Lv, Lingxiao Xing, Xianghong Zhang & Haitao Shen. (2020) Lung adenocarcinoma‐related TNF‐α‐dependent inflammation upregulates MHC‐II on alveolar type II cells through CXCR‐2 to contribute to Treg expansion. The FASEB Journal 34:9, pages 12197-12213.
Crossref
Crossref
Lina Such, Fang Zhao, Derek Liu, Beatrice Thier, Vu Thuy Khanh Le-Trilling, Antje Sucker, Christoph Coch, Natalia Pieper, Sebastian Howe, Hilal Bhat, Halime Kalkavan, Cathrin Ritter, Robin Brinkhaus, Selma Ugurel, Johannes Köster, Ulrike Seifert, Ulf Dittmer, Martin Schuler, Karl S. Lang, Thomas A. Kufer, Gunther Hartmann, Jürgen C. Becker, Susanne Horn, Soldano Ferrone, David Liu, Eliezer M. Van Allen, Dirk Schadendorf, Klaus Griewank, Mirko Trilling & Annette Paschen. (2020) Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy. Journal of Clinical Investigation.
Crossref
Crossref
Luke J. Nelson, Heather J. Wright, Nguyen B. Dinh, Kevin D. Nguyen, Olga V. Razorenova & F. Scott Heinemann. (2020) Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast Cancers. The American Journal of Pathology 190:2, pages 484-502.
Crossref
Crossref
Barbara Seliger & Soldano Ferrone. 2020. Biomarkers for Immunotherapy of Cancer. Biomarkers for Immunotherapy of Cancer
325
350
.
Sabine Heitzeneder, Elena Sotillo, Jack F Shern, Sivasish Sindiri, Peng Xu, Robert Jones, Michael Pollak, Pernille R Noer, Julie Lorette, Ladan Fazli, Anya Alag, Paul Meltzer, Ching Lau, Cheryl A Conover, Claus Oxvig, Poul H Sorensen, John M Maris, Javed Khan & Crystal L Mackall. (2019) Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion. JNCI: Journal of the National Cancer Institute 111:9, pages 970-982.
Crossref
Crossref
Mirco Compagnone, Loredana Cifaldi & Doriana Fruci. (2019) Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer. Human Immunology 80:5, pages 318-324.
Crossref
Crossref
Martin H. Pedersen, Brian L. Hood, Sidse Ehmsen, Hans C. Beck, Thomas P. Conrads, Martin Bak, Henrik J. Ditzel & Rikke Leth‐Larsen. (2018) CYPOR is a novel and independent prognostic biomarker of recurrence‐free survival in triple‐negative breast cancer patients. International Journal of Cancer 144:3, pages 631-640.
Crossref
Crossref
Yan Cheng, Cátia Monteiro, Andreia Matos, Jiaying You, Avelino Fraga, Carina Pereira, Victoria Catalán, Amaia Rodríguez, Javier Gómez-Ambrosi, Gema Frühbeck, Ricardo Ribeiro & Pingzhao Hu. (2018) Epigenome-wide DNA methylation profiling of periprostatic adipose tissue in prostate cancer patients with excess adiposity—a pilot study. Clinical Epigenetics 10:1.
Crossref
Crossref
María A. Garrido, Teresa Rodriguez, Svitlana Zinchenko, Isabel Maleno, Francisco Ruiz-Cabello, Ángel Concha, Nicolás Olea, Federico Garrido & Natalia Aptsiauri. (2018) HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15. Immunogenetics 70:10, pages 647-659.
Crossref
Crossref
Dana A. M. Mustafa, Rute M. S. M. Pedrosa, Marcel Smid, Marcel van der Weiden, Vanja de Weerd, Alex L. Nigg, Cor Berrevoets, Lona Zeneyedpour, Neibla Priego, Manuel Valiente, Theo M. Luider, Reno Debets, John W. M. Martens, John A. Foekens, Anieta M. Sieuwerts & Johan M. Kros. (2018) T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression. Acta Neuropathologica 135:4, pages 581-599.
Crossref
Crossref
Irene Romero, Cristina Garrido, Ignacio Algarra, Virginia Chamorro, Antonia Collado, Federico Garrido & Angel M. Garcia-Lora. (2018) MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy. Frontiers in Immunology 9.
Crossref
Crossref